Hydrogen Sulfide Protects the Brain Against Ischemic Reperfusion Injury in a Transient Model of Focal Cerebral Ischemia

Journal of Molecular Neuroscience

Volumn 54, Issue 2, 2014, Pages 264-270

  Gheibi, Sevda ^a   Aboutaleb, Nahid ^b   Khaksari, Mehdi ^c   Kalalian Moghaddam, Hamid ^c   Vakili, Abedin ^d   Asadi, Yasin ^d   Mehrjerdi, Fatemeh Zare ^e   Gheibi, Azam ^f  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHROUD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SEMNAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Apoptosis; Brain edema; H2S; Infarct volume; Transient focal cerebral ischemia

Indexed keywords

HYDROGEN SULFIDE; NEUROPROTECTIVE AGENT;

ANIMAL; APOPTOSIS; BRAIN; DRUG EFFECTS; EDEMA; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; PATHOLOGY; RAT; REPERFUSION INJURY; WISTAR RAT;

ANIMALS; APOPTOSIS; BRAIN; EDEMA; HYDROGEN SULFIDE; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR; REPERFUSION INJURY;

EID: 84896419951     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-014-0284-9     Document Type: Article

References (36)

1. Abe K, Kimura H (1996) The possible role of hydrogen sulfide as an endogenous neuromodulator. The Journal of neuroscience 16:1066–1071
2. Aboutaleb, N., Kalalianmoghaddam, H., Eftekhari, S., Shahbazi, A., Abbaspour, H. & Khaksari, M (2013). Apelin-13 inhibits apoptosis of cortical neurons following brain ischemic reperfusion injury in a transient model of focal cerebral ischemia. International Journal of Peptide Research and Therapeutics, 1–6.
3. Barone FC, Arvin B, White RF, Miller A, Webb CL, Willette RN, Lysko PG, Feuerstein GZ (1997) Tumor necrosis factor-α: a mediator of focal ischemic brain injury. Stroke 28:1233–1244
4. Bian J-S, Yong QC, Pan T-T, Feng Z-N, Ali MY, Zhou S, Moore PK (2006) Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes. J Pharmacol Exp Ther 316:670–678
5. Buttini M, Appel K, Sauter A, Gebicke-Haerter PJ, Boddeke H (1996) Expression of tumor necrosis factor alpha after focal cerebral ischaemia in the rat. Neuroscience 71:1–16
6. Chan PH (2001) Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab 21:2–14
7. Edwards JL, Vincent AM, Cheng HT, Feldman EL (2008) Diabetic neuropathy: mechanisms to management. Pharmacol Ther 120:1–34
8. Florian B, Vintilescu R, Balseanu AT, Buga A-M, Grisk O, Walker LC, Kessler C, Popa-Wagner A (2008) Long-term hypothermia reduces infarct volume in aged rats after focal ischemia. Neurosci Lett 438:180–185
9. Hu LF, Wong PTH, Moore PK, Bian JS (2007) Hydrogen sulfide attenuates lipopolysaccharide‐induced inflammation by inhibition of p38 mitogen‐activated protein kinase in microglia. J Neurochem 100:1121–1128
10. Jha S, Calvert JW, Duranski MR, Ramachandran A, Lefer DJ (2008) Hydrogen sulfide attenuates hepatic ischemia-reperfusion injury: role of antioxidant and antiapoptotic signaling. American Journal of Physiology-Heart and Circulatory Physiology 295:H801–H806
11. Johansen D, Ytrehus K (2006) Exogenous hydrogen sulfide (H2S) protects against regional myocardial ischemia–reperfusion injury. Basic Res Cardiol 101:53–60
12. Khaksari M, Aboutaleb N, Nasirinezhad F, Vakili A, Madjd Z (2012) Apelin-13 protects the brain against ischemic reperfusion injury and cerebral edema in a transient model of focal cerebral ischemia. J Mol Neurosci 48:201–208
13. Kimura Y, Kimura H (2004) Hydrogen sulfide protects neurons from oxidative stress. The FASEB journal 18:1165–1167
14. Kuroda S, Siesjö B (1997) Reperfusion damage following focal ischemia: pathophysiology and therapeutic windows. Clinical Neuroscience (New York, NY), 4, 199
15. Leeper NJ, Tedesco MM, Kojima Y, Schultz GM, Kundu RK, Ashley EA, Tsao PS, Dalman RL, Quertermous T (2009) Apelin prevents aortic aneurysm formation by inhibiting macrophage inflammation. American Journal of Physiology-Heart and Circulatory Physiology 296:H1329
16. Liu T, Clark RK, Mcdonnell PC, Young PR, White RF, Barone FC, Feuerstein GZ (1994) Tumor necrosis factor-alpha expression in ischemic neurons. Stroke 25:1481–1488
17. 2-induced neural injury via enhancing glutamate uptake. Free Radic Biol Med 45:1705–1713
18. Luo, Y, Yang X, Zhao S, Wei C, Yin Y, Liu T, Jiang S, Xie J, Wan X, Mao M (2013) Hydrogen Sulfide Prevents OGD/R-induced apoptosis via improving mitochondrial dysfunction and suppressing an ROS-mediated caspase-3 pathway in cortical neurons. Neurochemistry international
19. Minamishima S, Bougaki M, Sips PY, De Yu J, Minamishima YA, Elrod JW, Lefer DJ, Bloch KD, Ichinose F (2009) Hydrogen sulfide improves survival after cardiac arrest and cardiopulmonary resuscitation via a nitric oxide synthase 3-dependent mechanism in mice. Circulation 120:888–896
20. Nawashiro H, Martin D, Hallenbeck JM (1997a) Inhibition of tumor necrosis factor and amelioration of brain infarction in mice. J Cereb Blood Flow Metab 17:229–232
21. Nawashiro H, Tasaki K, Ruetzler CA, Hallenbeck JM (1997b) TNF-α pretreatment induces protective effects against focal cerebral ischemia in mice. J Cereb Blood Flow Metab 17:483–490
22. Oh SM, Betz AL (1991) Interaction between free radicals and excitatory amino acids in the formation of ischemic brain edema in rats. Stroke 22:915–921
23. Rolo AP, Palmeira CM (2006) Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol Appl Pharmacol 212:167–178
24. Sivarajah A, Mcdonald M, Thiemermann C (2006) The production of hydrogen sulfide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of preconditioning with endotoxin, but not ischemia in the rat. Shock 26:154–161
25. Slivka A, Murphy E, Horrocks L (1995) Cerebral edema after temporary and permanent middle cerebral artery occlusion in the rat. Stroke 26:1061–1066
26. Swanson RA, Morton MT, Tsao-Wu G, Savalos RA, Davidson C, Sharp FR (1990) A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 10:290–293
27. Szabó C (2007) Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov 6:917–935
28. Tan BH, Wong PT-H, Bian J-S (2010) Hydrogen sulfide: a novel signaling molecule in the central nervous system. Neurochem Int 56:3–10
29. Tyagi N, Moshal KS, Sen U, Vacek TP, Kumar M, Hughes Jr WM, Kundu S, Tyagi SC (2009) H2S protects against methionine-induced oxidative stress in brain endothelial cells. Antioxidants & redox signaling 11:25–33
30. Vakili A, Kataoka H, Plesnila N (2005) Role of arginine vasopressin V1 and V2 receptors for brain damage after transient focal cerebral ischemia. J Cereb Blood Flow Metab 25:1012–1019
31. Wang R (2002) Two’s company, three’s a crowd: can H2S be the third endogenous gaseous transmitter? The FASEB journal 16:1792–1798
32. White BC, Sullivan JM, Degracia DJ, O’neil BJ, Neumar RW, Grossman LI, Rafols JA, Krause GS (2000) Brain ischemia and reperfusion: molecular mechanisms of neuronal injury. J Neurol Sci 179:1–33
33. Yao L-L, Huang X-W, Wang Y-G, Cao Y-X, Zhang C-C, Zhu Y-C (2010) Hydrogen sulfide protects cardiomyocytes from hypoxia/reoxygenation-induced apoptosis by preventing GSK-3β-dependent opening of mPTP. American Journal of Physiology-Heart and Circulatory Physiology 298:H1310–H1319
34. +-induced apoptosis in PC12 cells. Life Sci 85:269–275
35. Zhang L-M, Jiang C-X, Liu D-W (2009) Hydrogen sulfide attenuates neuronal injury induced by vascular dementia via inhibiting apoptosis in rats. Neurochem Res 34:1984–1992
36. Zoppo G, Ginis I, Hallenbeck JM, Iadecola C, Wang X, Feuerstein GZ (2000) Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia. Brain Pathol 10:95–112